Anzeige
Mehr »
Login
Dienstag, 22.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Goldpreise steigen über $2.700 - Hier ist der Bergbaukonzern, der jetzt davon profitieren könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
63 Leser
Artikel bewerten:
(0)

New Laptops Come with 'Anti-Theft' Technology Built-In

VANCOUVER, Feb. 1 /PRNewswire-FirstCall/ -- Absolute Software ("Absolute") (TSX-VEN: ABT), the leading provider of PC Theft Recovery and Secure Asset Tracking(TM) solutions, today announced that IBM is now embedding support for Absolute's Computrace(R) solutions into the BIOS firmware of their new ThinkPad computers, starting with the new T-series.

Absolute's Computrace technology powers Absolute's Guaranteed PC Theft Recovery and Secure Asset Tracking services. In the event a computer is stolen, Absolute guarantees the recovery of the computer, and can remotely delete sensitive data from the stolen computer when data privacy is a concern. If the computer is not recovered within 30-60 days, the customer may be eligible for a Recovery Guarantee payment of up to $1000(x). In addition, Absolute provides customers with a cost-effective solution for tracking computer location, providing computer hardware/software inventories, managing lease returns and enabling software title tracking and license compliance.

"Education experiences a great deal of computer theft and Absolute's Computrace is the best solution we've found for recovering stolen PCs and deterring theft," said Philip Lombardi, Director of Academic Computing & Media Services at Bryant University. "With IBM placing Computrace in the BIOS, our ThinkPads are the most secure notebooks that we have considered purchasing. It's like having an undetectable security cable connected to all our remote and mobile computers. On a daily basis Computrace improves our ability to track and manage our computers assets no matter where they are, and in critical situations it goes one step further, and helps us recover our stolen PCs quickly - in all, Computrace saves us both time and money."

"With our software included in the IBM ThinkPad BIOS, our 'Anti-Theft' technology evolves from tamper-resistant to tamper-proof," said John Livingston, Chairman and CEO of Absolute Software. "Greater emphasis is being placed on the security and protection of remote and mobile computing assets that contain sensitive and confidential information. The timing is right for Absolute to deliver this type of value-added security service. This is a key milestone for Absolute in driving the industry standard for PC Theft Recovery and Secure Asset Tracking services."


IBM ThinkPads, starting with the new T-Series, will come Computrace-enabled. In order to activate the service, customers will need to purchase a subscription to Absolute's Computrace service from Absolute or IBM(xx), and must contact Absolute to activate the service.

(x) Certain terms and conditions apply - see http://www.absolute.com/ for details (xx) Absolute Software, Inc, not IBM, is solely responsible for service. About Absolute

Absolute(R) Software (TSX VEN: ABT) is the leader in PC Theft Recovery and Secure Asset Tracking(TM) with more than 325,000 subscriptions under management. Absolute's uniquely patented Computrace(R) technology is optimized for remote and mobile users. Absolute Software provides organizations with simple and cost effective solutions to help track their computing assets, deter computer loss, and reduce incurred liability costs. Absolute Software has a history of delivering first-to-market technology innovations along with a recovery guarantee making it one of the most reliable asset tracking and recovery solutions in the market today. The company also has partnerships with global leaders, including, Dell, IBM, HP, Toshiba, Gateway, Phoenix Technologies, and Apple.

Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, and other expectations, intentions and plans contained in this press release that are not historical fact. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and general market conditions. In light of the many risks and uncertainties you should understand that we cannot assure you that the forward-looking statements contained in this press release will be realized.

For more information please contact Absolute Software: John Livingston, Chief Executive Officer jliving@absolute.com Rob Chase, Chief Financial Officer rchase@absolute.com Ben Haidri, VP Marketing and Business Development bhaidri@absolute.com Phone: (604) 730-9851 or (800) 220-0733 http://www.absolute.com/ (C)2005 Absolute Software Corporation. All rights reserved. Computrace and Absolute are registered trademarks of Absolute Software Corporation. All other trademarks are property of their respective owners. Computrace US patents No. 5,715,174, No. 5,764,892, No. 5,802,280, No. 6,244,758, No. 6,269,392, No. 6,300,863, and No. 6,507,914. Canadian patent No. 2,305,370. U.K patents No. EP793823, and No. GB2338101. German patent No. 695 125 34.6-08. Australian patent No. 699045.

The TSX Venture Exchange has neither approved nor disapproved of the information contained in this news release.

Absolute Software Corporation
© 2005 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.